J M Bolscher1, K M J Koolen1, G J van Gemert2, M G van de Vegte-Bolmer2, T Bousema2, D Leroy3, R W Sauerwein4, K J Dechering5. 1. TropIQ Health Sciences, Geert Grooteplein 28, huispost 268, 6525 GA, Nijmegen, The Netherlands. 2. Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands. 3. Medicines for Malaria Venture, Route de Pré-Bois 20, 1215 Geneva 15, Switzerland. 4. TropIQ Health Sciences, Geert Grooteplein 28, huispost 268, 6525 GA, Nijmegen, The Netherlands Radboud University Nijmegen Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands. 5. TropIQ Health Sciences, Geert Grooteplein 28, huispost 268, 6525 GA, Nijmegen, The Netherlands k.dechering@tropiq.nl.
Abstract
OBJECTIVES: The development of drugs to reduce malaria transmission is an important part of malaria eradication plans. We set out to develop and validate a combination of new screening assays for prioritization of transmission-blocking molecules. METHODS: We developed high-throughput assays for screening compounds against gametocytes, the parasite stages responsible for onward transmission to mosquitoes. An existing gametocyte parasitic lactate dehydrogenase (pLDH) assay was adapted for use in 384-well plates, and a novel homogeneous immunoassay to monitor the functional transition of female gametocytes into gametes was developed. A collection of 48 marketed and experimental antimalarials was screened and subsequently tested for impact on sporogony in Anopheles mosquitoes, to directly quantify the transmission-blocking properties of antimalarials in relation to their effects on gametocyte pLDH activity or gametogenesis. RESULTS AND CONCLUSIONS: The novel screening assays revealed distinct stage-specific kinetics and dynamics of drug effects. Peroxides showed the most potent transmission-blocking effects, with an intermediate speed of action and IC50 values that were 20-40-fold higher than the IC50s against the asexual stages causing clinical malaria. Finally, the novel synthetic peroxide OZ439 appeared to be a promising drug candidate as it exerted gametocytocidal and transmission-blocking effects at clinically relevant concentrations.
OBJECTIVES: The development of drugs to reduce malaria transmission is an important part of malaria eradication plans. We set out to develop and validate a combination of new screening assays for prioritization of transmission-blocking molecules. METHODS: We developed high-throughput assays for screening compounds against gametocytes, the parasite stages responsible for onward transmission to mosquitoes. An existing gametocyte parasitic lactate dehydrogenase (pLDH) assay was adapted for use in 384-well plates, and a novel homogeneous immunoassay to monitor the functional transition of female gametocytes into gametes was developed. A collection of 48 marketed and experimental antimalarials was screened and subsequently tested for impact on sporogony in Anopheles mosquitoes, to directly quantify the transmission-blocking properties of antimalarials in relation to their effects on gametocyte pLDH activity or gametogenesis. RESULTS AND CONCLUSIONS: The novel screening assays revealed distinct stage-specific kinetics and dynamics of drug effects. Peroxides showed the most potent transmission-blocking effects, with an intermediate speed of action and IC50 values that were 20-40-fold higher than the IC50s against the asexual stages causing clinical malaria. Finally, the novel synthetic peroxideOZ439 appeared to be a promising drug candidate as it exerted gametocytocidal and transmission-blocking effects at clinically relevant concentrations.
Authors: Manu Vanaerschot; Leonardo Lucantoni; Tao Li; Jill M Combrinck; Andrea Ruecker; T R Santha Kumar; Kelly Rubiano; Pedro E Ferreira; Giulia Siciliano; Sonia Gulati; Philipp P Henrich; Caroline L Ng; James M Murithi; Victoria C Corey; Sandra Duffy; Ori J Lieberman; M Isabel Veiga; Robert E Sinden; Pietro Alano; Michael J Delves; Kim Lee Sim; Elizabeth A Winzeler; Timothy J Egan; Stephen L Hoffman; Vicky M Avery; David A Fidock Journal: Nat Microbiol Date: 2017-08-14 Impact factor: 17.745
Authors: Dina Coertzen; Janette Reader; Mariëtte van der Watt; Sindisiwe H Nondaba; Liezl Gibhard; Lubbe Wiesner; Peter Smith; Sarah D'Alessandro; Donatella Taramelli; Ho Ning Wong; Jan L du Preez; Ronald Wai Keung Wu; Lyn-Marie Birkholtz; Richard K Haynes Journal: Antimicrob Agents Chemother Date: 2018-07-27 Impact factor: 5.191
Authors: Tanya Paquet; Claire Le Manach; Diego González Cabrera; Yassir Younis; Philipp P Henrich; Tara S Abraham; Marcus C S Lee; Rajshekhar Basak; Sonja Ghidelli-Disse; María José Lafuente-Monasterio; Marcus Bantscheff; Andrea Ruecker; Andrew M Blagborough; Sara E Zakutansky; Anne-Marie Zeeman; Karen L White; David M Shackleford; Janne Mannila; Julia Morizzi; Christian Scheurer; Iñigo Angulo-Barturen; María Santos Martínez; Santiago Ferrer; Laura María Sanz; Francisco Javier Gamo; Janette Reader; Mariette Botha; Koen J Dechering; Robert W Sauerwein; Anchalee Tungtaeng; Pattaraporn Vanachayangkul; Chek Shik Lim; Jeremy Burrows; Michael J Witty; Kennan C Marsh; Christophe Bodenreider; Rosemary Rochford; Suresh M Solapure; María Belén Jiménez-Díaz; Sergio Wittlin; Susan A Charman; Cristina Donini; Brice Campo; Lyn-Marie Birkholtz; Kirsten K Hanson; Gerard Drewes; Clemens H M Kocken; Michael J Delves; Didier Leroy; David A Fidock; David Waterson; Leslie J Street; Kelly Chibale Journal: Sci Transl Med Date: 2017-04-26 Impact factor: 17.956
Authors: Matthew M Ippolito; Julia Johnson; Christopher Mullin; Christopher Mallow; Nadia Morgan; Erika Wallender; Tianjing Li; Philip J Rosenthal Journal: Clin Infect Dis Date: 2017-08-01 Impact factor: 9.079
Authors: Tao Li; Abraham G Eappen; Adam M Richman; Peter F Billingsley; Yonas Abebe; Minglin Li; Debbie Padilla; Isabel Rodriguez-Barraquer; B Kim Lee Sim; Stephen L Hoffman Journal: Malar J Date: 2015-04-09 Impact factor: 2.979
Authors: Martijn W Vos; Will J R Stone; Karin M Koolen; Geert-Jan van Gemert; Ben van Schaijk; Didier Leroy; Robert W Sauerwein; Teun Bousema; Koen J Dechering Journal: Sci Rep Date: 2015-12-21 Impact factor: 4.379